Zepzelca–Tecentriq Combination Approved for Maintenance Treatment of Extensive – Stage Small Cell Lung Cancer in Canada, Qatar and South Korea – PharmaMar
PharmaMar announced that health authorities in Canada, Qatar and South Korea have approved Zepzelca (lurbinectedin) in combination with atezolizumab (Tecentriq) for the maintenance treatment for adult patients with… read more.
